# A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

> **NCT00138671** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 105 (actual)

## Conditions studied

- Diabetes Mellitus
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Subcutaneous Insulin
- **DRUG:** Inhaled Insulin

## Key facts

- **NCT ID:** NCT00138671
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-01
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 105 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2010-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00138671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00138671, "A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00138671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*